Michael Shulman is the Editor of ChangeWave Biotech Investor, a newsletter advisory service that follows life sciences and biotech stocks. He also served as Managing Director of Research for ChangeWave Research for four years, where he produced technology and healthcare research for financial institutions.

Michael also runs an options trading service designed to help you ride stocks to the downside. ChangeWave Shorts positions you for big profits while limiting your risk by using put option strategies designed to help you "short" companies, indexes and Exchange-Traded Funds that are set to take a tumble. He takes advantage of targeted ChangeWave Alliance surveys to uncover trends before other investors—and Wall Street—take notice.

We focus purely on fundamental indicators—examining business models, product lines, how the broader sectors are doing and where consumer—or corporate-level customers are planning (or, rather, NOT planning) to spend their money. And many options traders only buy calls, but buying puts is a similarly limited-risk strategy that opens up the "other" side of the market (i.e., the downside) so that, the farther stocks drop, the bigger your returns can pop!

Michael joined ChangeWave after spending 20 years in various high-tech industries. Prior to joining ChangeWave, Michael was the CEO of AtYourBusiness.com, now Primewire, a benefits administration Application Service Provider he founded in 1998.

Michael began his career doing in-depth company and market analysis for a variety of companies, building databases and simulation models to estimate the success of various technologies across a wide range of market segments. He moved "inside" the high-tech community as a manager at high-tech companies including AT&T.

Michael was an early private investor in several Internet start-ups, notably XOOM.com (which went public in 1998 and was bought by NBC in 1999), and brings a unique perspective to the ChangeWave research effort as a combination of technologist, investor and financial analyst.

He has been published in a variety of trade and general business publications, including the Los Angeles Times, and is a frequent guest on CNBC's "Squawk Box."